Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Credit Suisse cuts AstraZeneca and raises GSK

Thu, 15th Sep 2022 09:30

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Friday:

----------

FTSE 100

----------

Credit Suisse cuts AstraZeneca to 'neutral' (outperform) - price target 11,000 pence

----------

Credit Suisse raises GSK to 'neutral' (underperform) - price target 1,430 (1,630) pence

----------

Jefferies cuts Hikma Pharmaceutical price target to 2020 (2290) pence - 'buy'

----------

Berenberg cuts Admiral Group price target to 2,819 (2,903) pence - 'buy'

----------

Berenberg raises InterContinental Hotels target to 6,500 (5,700) pence - 'buy'

----------

Barclays cuts Whitbread price target to 3,500 (4,000) pence - 'overweight'

----------

Berenberg cuts Howden Joinery group price target to 620 (780) pence - 'hold'

----------

RBC cuts Dechra Pharma price target to 4,000 (4,200) pence - 'outperform'

----------

HSBC raises BT Group to 'buy' (hold)

----------

FTSE 250

----------

JPMorgan raises Trainline price target to 425 (420) pence - 'neutral'

----------

Berenberg cuts Volution price target to 460 (550) pence - 'buy'

----------

Berenberg cuts Travis Perkins price target to 910 (1,000) pence - 'hold'

----------

Berenberg cuts Marshalls price target to 380 (400) pence - 'hold'

----------

Berenberg cuts Ibstock price target to 180 (210) pence - 'hold'

----------

Berenberg cuts Genuit price target to 470 (530) pence - 'buy'

----------

Berenberg starts Currys with 'hold' - price target 70 pence

----------

Barclays cuts John Wood Group price target to 250 (320) pence - 'overweight'

----------

Barclays cuts C&C Group price target to 230 (240) pence - 'overweight'

----------

Citigroup raises Tate & Lyle to 'buy' (neutral) - price target 850 pence

----------

Goldman Sachs cuts Marks & Spencer price target to 125 (140) pence - 'sell'

----------

Jefferies cuts Redrow price target to 768 (780) pence - 'buy'

----------

SMALL CAP

----------

Morgan Stanley raises AIB target to 3 (2,80) EUR - 'equal-weight'

----------

Morgan Stanley raises Bank of Ireland target to 7,60 (7,40) EUR - 'equal-weight'

----------

Jefferies cuts DFS Furniture price target to 210 (270) pence - 'buy'

----------

Berenberg cuts Eurocell price target to 250 (310) pence - 'buy'

----------

Berenberg cuts Central Asia Metals price target to 300 (310) pence - 'buy'

----------

Berenberg cuts Forterra price target to 250 (270) pence - 'hold'

----------

Berenberg cuts Breedon price target to 80 (100) pence - 'buy'

----------

Goldman Sachs cuts ITM Power price target to 120 (220) pence - 'sell'

----------

HSBC cuts Johnson Service Group to 'hold' (buy)

----------

Bank of America raises Fevertree Drinks price target to 1,030 (950) pence - 'neutral'

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.